Vikas Sindwani, Applied Intelligence Delivery Lead, Accenture, Loic Giraud, Novartis Head of Analytics COE, Novartis, & Fang Deng, Big Data & Advanced Analytics Program Lead, Analytics COE, Novartis sits down with Rebecca Knight at Accenture Executive Summit at AWS re:Invent 2019 in Las Vegas, NV.
#reInvent #Accenture #theCUBE
https://siliconangle.com/2019/12/17/novartis-embraces-digital-world-reimagine-medicine-patients-reinvent/
Novartis embraces the digital world to reimagine medicine for patients
In a highly regulated space such as the pharmaceutical industry, the process of digital transformation has been slower than in other sectors. However, the Swiss pharmaceutical giant Novartis AG has been focused on changing this narrative in recent years as it embraced digital and data.
“We are trying to reimagine medicine through user data and technology,” said Loic Giraud (pictured, center), business analytics COE head at Novartis. “We’re trying to optimize the backbone of our day-to-day processes. Through the cloud we can make use of data to innovate, operate and engage.”
Giraud spoke with Rebecca Knight (@knightrm), host of theCUBE, SiliconANGLE Media’s mobile livestreaming studio, during the Accenture Executive Summit at the AWS re:Invent event in Las Vegas. He was joined by Fang Deng (pictured, right), big data and advanced analytics program lead at Novartis, and Vikas Sindwani (pictured, left), principal director of applied intelligence at Accenture. They discussed how Novartis is reimagining new products for patients using digital technologies and a growing industry acceptance of the cloud. (* Disclosure below.)
Leveraging massive data pool
Novartis has developed a new platform — Nerve Live — which is designed to leverage the firm’s massive data pool. Faster and more thorough analysis of data, using artificial intelligence and machine learning, will help the company research and develop new drug therapies.
“We’re trying to reimagine our products for the patient,” Deng said. “Our objective is to leverage new technologies, concentrate on data in the cloud, and build a new platform for Novartis users.”
The pharmaceutical company is also embracing the cloud. Earlier this month, Novartis announced that it would work with Amazon Web Services Inc. to overhaul its manufacturing and business operations.
“Companies like healthcare, media, metals and mining were behind the curve in cloud-adoption rates because of their respective concerns around compliance and security of data,” Sindwani explained. “That trend is slowly shifting as companies are becoming more open. They’ve seen how the public cloud has matured.”
Watch the complete video interview below, and be sure to check out more of SiliconANGLE’s and theCUBE’s coverage of the Accenture Executive Summit during the AWS re:Invent event. (* Disclosure: Accenture LLP sponsored this segment of theCUBE. Neither Accenture nor other sponsors have editorial control over content on theCUBE or SiliconANGLE.)
Forgot Password
Almost there!
We just sent you a verification email. Please verify your account to gain access to
Accenture Executive Summit 2019 | Las Vegas. If you don’t think you received an email check your
spam folder.
Sign in to Accenture Executive Summit 2019 | Las Vegas.
In order to sign in, enter the email address you used to registered for the event. Once completed, you will receive an email with a verification link. Open this link to automatically sign into the site.
Register For Accenture Executive Summit 2019 | Las Vegas
Please fill out the information below. You will recieve an email with a verification link confirming your registration. Click the link to automatically sign into the site.
You’re almost there!
We just sent you a verification email. Please click the verification button in the email. Once your email address is verified, you will have full access to all event content for Accenture Executive Summit 2019 | Las Vegas.
I want my badge and interests to be visible to all attendees.
Checking this box will display your presense on the attendees list, view your profile and allow other attendees to contact you via 1-1 chat. Read the Privacy Policy. At any time, you can choose to disable this preference.
Select your Interests!
add
Upload your photo
Uploading..
OR
Connect via Twitter
Connect via Linkedin
EDIT PASSWORD
Share
Forgot Password
Almost there!
We just sent you a verification email. Please verify your account to gain access to
Accenture Executive Summit 2019 | Las Vegas. If you don’t think you received an email check your
spam folder.
Sign in to Accenture Executive Summit 2019 | Las Vegas.
In order to sign in, enter the email address you used to registered for the event. Once completed, you will receive an email with a verification link. Open this link to automatically sign into the site.
Sign in to gain access to Accenture Executive Summit 2019 | Las Vegas
Please sign in with LinkedIn to continue to Accenture Executive Summit 2019 | Las Vegas. Signing in with LinkedIn ensures a professional environment.
Vikas Sindwani, Applied Intelligence Delivery Lead, Accenture, Loic Giraud, Novartis Head of Analytics COE, Novartis, & Fang Deng, Big Data & Advanced Analytics Program Lead, Analytics COE, Novartis sits down with Rebecca Knight at Accenture Executive Summit at AWS re:Invent 2019 in Las Vegas, NV.
#reInvent #Accenture #theCUBE
https://siliconangle.com/2019/12/17/novartis-embraces-digital-world-reimagine-medicine-patients-reinvent/
Novartis embraces the digital world to reimagine medicine for patients
In a highly regulated space such as the pharmaceutical industry, the process of digital transformation has been slower than in other sectors. However, the Swiss pharmaceutical giant Novartis AG has been focused on changing this narrative in recent years as it embraced digital and data.
“We are trying to reimagine medicine through user data and technology,” said Loic Giraud (pictured, center), business analytics COE head at Novartis. “We’re trying to optimize the backbone of our day-to-day processes. Through the cloud we can make use of data to innovate, operate and engage.”
Giraud spoke with Rebecca Knight (@knightrm), host of theCUBE, SiliconANGLE Media’s mobile livestreaming studio, during the Accenture Executive Summit at the AWS re:Invent event in Las Vegas. He was joined by Fang Deng (pictured, right), big data and advanced analytics program lead at Novartis, and Vikas Sindwani (pictured, left), principal director of applied intelligence at Accenture. They discussed how Novartis is reimagining new products for patients using digital technologies and a growing industry acceptance of the cloud. (* Disclosure below.)
Leveraging massive data pool
Novartis has developed a new platform — Nerve Live — which is designed to leverage the firm’s massive data pool. Faster and more thorough analysis of data, using artificial intelligence and machine learning, will help the company research and develop new drug therapies.
“We’re trying to reimagine our products for the patient,” Deng said. “Our objective is to leverage new technologies, concentrate on data in the cloud, and build a new platform for Novartis users.”
The pharmaceutical company is also embracing the cloud. Earlier this month, Novartis announced that it would work with Amazon Web Services Inc. to overhaul its manufacturing and business operations.
“Companies like healthcare, media, metals and mining were behind the curve in cloud-adoption rates because of their respective concerns around compliance and security of data,” Sindwani explained. “That trend is slowly shifting as companies are becoming more open. They’ve seen how the public cloud has matured.”
Watch the complete video interview below, and be sure to check out more of SiliconANGLE’s and theCUBE’s coverage of the Accenture Executive Summit during the AWS re:Invent event. (* Disclosure: Accenture LLP sponsored this segment of theCUBE. Neither Accenture nor other sponsors have editorial control over content on theCUBE or SiliconANGLE.)
